| 摘要 |
FIELD: medicine. ^ SUBSTANCE: subtype of stroke is determined based on the clinical, instrumenta; and biochemical tests, and the differentiated therapy is performed by use of one or few of following 4 treatments and taking in account the concomitant diseases, contraindications and stroke type: 1) antithrombotic therapy (AT), 2) hypotensive therapy (HtT), 3) hypolipidemic therapy (HlT), 4) surgery (S). The AT is used in life-long cardioembolic aterothrombotic ischemic stroke. The HtT is administered to all patients with stroke; HlT is used in patients without diabetes and after the low-cholesterol diet within 6 months, with plasma cholesterol more than 5.5 mmol/L or 220 mg/dL, or in patients with diabetes I or II with plasma cholesterol more than 3.2 mmol/L or 128 mg/dL, on agreement with endocrinologist. S is used in patients with 50-70% stenosis of head and neck blood vessels and in embologenic plaque, or if stenosis if more than 70%. ^ EFFECT: complex effect upon different pathogenetic levels of stroke is provided, and patient's individual characteristics are taken in account. ^ 3 cl, 3 tbl, 4 ex |
